Developing the Next Generation of CAR-T to Treat Solid Tumours

Time: 8:00 am
day: Day Two


• Developing autologous T-cells to treat solid tumours using non-viral genome editing
• Designing combinatorial synthetic biology to engineer the fate and function of therapeutic T-cells
• Creating first-in class autologous T-cell products for solid tumours